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On August 12, 2020, the U.S. Food and Drug Administration (FDA) has finalized a rule related
to gluten-free labeling for foods containing fermented, hydrolyzed ingredients. The FDA believes
that there is no scientifically valid analytical method effective for determining gluten in fermented
or hydrolyzed foods. In the absence of an analytical method, the FDA has decided to evaluate
gluten-free claims on these foods based only on evidence that the food or ingredient used is
gluten-free before fermentation or hydrolysis. For example, barley-based beers from which gluten
is removed during brewing using special filtration, adsorption and/or enzymatic treatment are
therefore excluded from bearing a gluten-free label.
The Prolamin Working Group (PWG) acknowledges that the FDA rule is a regulatory act and
might have to take into consideration several aspects other than scientific evidence, including risk
assessment. Nevertheless, the PWG thinks that science has to be the most important driver for
regulatory acts in risk management.
In contrast, in the EU such beers are currently allowed to bear a gluten-free label. As required
by Regulation (EU) No 1169/2011 of 25 October 2011 on the provision of food information
to consumers, the ingredients list must include “barley malt” in highlighted lettering, because
gluten-containing cereals are listed in Annex II of the Regulation as substances or products
causing allergies or intolerances. The maximum gluten level to bear a gluten-free claim is set
in Regulation (EU) No 828/2014 of 30 July 2014 on the requirements for the provision of
information to consumers on the absence or reduced presence of gluten in food. On this legal basis,
non-governmental Organizations such as the Association of European Coeliac Societies (AOECS)
have developed the European Licensing System with guidelines that have to be met to allow using
the crossed grain symbol for gluten-free food on the label.
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This difference of regulation is a topic of much debate at
the moment, because of the divergent opinions between the
FDA and the EU. Today, enzyme-linked immunosorbent assays
(ELISAs) are the methods of choice for gluten quantitation and
are widely used in routine analysis of gluten in food. The R5
antibody, the most prevalent monoclonal antibody used in gluten
analysis, was developed by Enrique Mendez, a member of the
PWG and is available as a Sandwich ELISA for intact gluten
and a competitive ELISA for partially hydrolyzed gluten. The
R5 Sandwich ELISA has been endorsed by Codex Alimentarius
as a Type 1 method to determine gluten in food. However, the
Sandwich format is not suitable to determine gluten in products
containing partially hydrolyzed gluten, and competitive ELISAs
are required for this type of analysis. Competitive ELISAs based
on either R5, G12 or DQ2.5-glia-α3 antibodies are currently
available, even if their use is not yet fully approved by official food
control authorities. The following statements on the R5 ELISA
might be also valid for other competitive ELISAs. Based on the
available scientific studies, the PWG thinks that the competitive
R5 ELISA is suitable to determine the gluten content of fermented
foods containing partially hydrolyzed gluten from wheat, rye or
barley, such as beer. The PWG acknowledges that this method
has limitations because it might miss smaller peptide fragments
and might not have the perfect standard to account for the
vast variety of different fermentation procedures common in
food processing. However, this method has been validated by
an international collaborative study under the guidance of the
PWG in 2013. Beer spiked with partially hydrolyzed gluten,
naturally gluten-contaminated starch syrup and dried sourdough
were used as matrices. The collaborative study was successful
and the R5 competitive ELISA was subsequently approved by the
respective expert panels as AACCI Method 38-55.01 and AOAC
Official Method of Analysis (Final Action OMA 2015.05) because
the method was shown to be accurate, precise and specific for
its intended purpose. An additional study was initiated with
internationally known experts to show the reliability of the R5
competitive ELISA method for the investigation of beer samples.
A subcommittee of the American Society of Brewing Chemists
recommended that the method for gluten determination by R5
competitive ELISA be included in their Methods of Analysis. The
PWG therefore considers that this method is currently state-of-
the-art to quantitate gluten in fermented foods.
The FDA thinks that the R5 competitive ELISA method is
not suitable for the detection and quantitation of gluten in any
fermented or hydrolyzed food because of different hydrolytic
conditions in the food to be analyzed and in the material used
for calibration. This opinion is scientifically correct but following
this reasoning would imply that a different calibrator has to be
prepared for each sample matrix, i.e., for each type of beer, even
from the same producer. Thus, standardization of the method
would be impossible and results would not be comparable
between different laboratories or manufacturers. This would be
a step back in gluten analysis. Furthermore, the same issue also
applies to other methods used for gluten analysis, e.g., sandwich
ELISA or liquid chromatography tandem mass spectrometry
(LC-MS/MS). In this field of research, calibrators are always a
compromise between different possibilities.
The most important alternative method to detect gluten in
fermented foods is LC-MS/MS. This technique is currently able
to detect and quantify gluten fragments (peptides) in beers but so
far there is no validated routinemethod to give absolute values for
the gluten content based on these fragments. The PWG has not
seen any values in mg/kg of a CD-active peptide that would really
allow to make a good statement if these traces would be relevant
to CD patients or if the contents are so low that they fall below
the 20 mg/kg threshold for gluten-free foods. Even if modern MS
equipment is able to detect femtomolar amounts of peptides, a
proper risk assessment of the detected contents is not available.
It is often said that the R5 competitive ELISA does not provide
information on the immunogenicity of the detected fragments.
However, this is also true for alternative analytical methods for
gluten quantitation, and, in addition, this is not the intended
use of the method. Food analytical methods can only determine
the content of an analyte and are relevant for the decision if
this analyte is below or above a threshold set by legislation.
Immunogenicity can only be evaluated in clinical studies.
The PWG thinks that more scientific studies are needed to
(i) better understand MS-detection of residual gluten in beer
and other fermented foods and also (ii) to ensure that the R5
competitive ELISA picks up each peptide fragment it should.
Also, MS detection and quantitation of gluten fragments is not
feasible for food manufacturers, in particular small companies,
because it is too expensive and too demanding in terms of time
and skill of the operators. Thus, it is difficult to recommend
it as a routine testing method also having in mind that a
proper method for absolute gluten quantitation by MS is not
available so far.
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